Pure Global
NCT05421715

Remote Digital Care Effects in Adolescents With Type 1 Diabetes

Preliminary Study for the Evaluation of Teleduc-diab Additional Remote Digitalcare Effects in Adolescents With Poorly Controled Type 1 Diabetes
University Hospital, Toulouse·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
type1diabetes
Drug/Device/Intervention
TELEDUC-DIAB
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University Hospital, Toulouse
Timeline & enrollment
Phase
N/A
Start date
Oct 01, 2022
End date
Dec 01, 2024
Enrollment
30 participants
Primary outcome

Evolution of glycemic control hemoglobin (HbA1c) between inclusion and 6 months

Summary

Pilot study to evaluate effects of an experimental additional remote digital care
 (TELEDUC-DIAB) to adolescents with poorly controlled type 1 diabetes using digital monitoring
 platform and educative app

ICD-10 classifications
Type 1 diabetes mellitusType 1 diabetes mellitus with unspecified complicationsType 1 diabetes mellitus with other specified complicationsType 1 diabetes mellitus without complicationsType 1 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05421715
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05421715 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital, Toulouse and is currently Not yet recruiting. The study focuses on type1diabetes. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.